QXO (QXO) had the highest return in Q4 2023 by a US stock with a market cap of $2B+, returning 416.9%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
QXO (QXO) | Q4 2023 | 416.92% |
Immunitybio (IBRX) | Q4 2023 | 195.29% |
Cytokinetics (CYTK) | Q4 2023 | 184.37% |
Scholar Rock (SRRK) | Q4 2023 | 166.67% |
CleanSpark (CLSK) | Q4 2023 | 164.73% |
Ondas (ONDS) | Q4 2023 | 150.41% |
Affirm (AFRM) | Q4 2023 | 132.01% |
Coinbase Global (COIN) | Q4 2023 | 121.41% |
Xometry (XMTR) | Q4 2023 | 111.73% |
Galaxy Digital (GLXY) | Q4 2023 | 106.1% |
American Bitcoin (ABTC) | Q4 2023 | 104.23% |
TG Therapeutics (TGTX) | Q4 2023 | 102.13% |
Rhythm Pharmaceuticals (RYTM) | Q4 2023 | 100.57% |
Gap (GAP) | Q4 2023 | 98.92% |
Edgewise Therapeutics (EWTX) | Q4 2023 | 90.92% |
Snap (SNAP) | Q4 2023 | 90.87% |
Liquidia Technologies (LQDA) | Q4 2023 | 89.75% |
Aurora Innovation (AUR) | Q4 2023 | 87.55% |
Kymera Therapeutics (KYMR) | Q4 2023 | 83.83% |
Twist Bioscience (TWST) | Q4 2023 | 83.57% |
IREN (IREN) | Q4 2023 | 82.86% |
MicroStrategy (MSTR) | Q4 2023 | 82.25% |
Rocket Companies (RKT) | Q4 2023 | 79.88% |
Compania de Minas Buenaventura SAA ADR (BVN) | Q4 2023 | 79.5% |
Spyre Therapeutics (SYRE) | Q4 2023 | 78.74% |
